Kho M R, Baker D J, Laayoun A, Smith S S
Department of Cell and Tumor Biology, City of Hope National Medical Center, Duarte, CA 91010-300, USA.
J Mol Biol. 1998 Jan 9;275(1):67-79. doi: 10.1006/jmbi.1997.1430.
Single-strand conformers (SSCs) from the C-rich strand of the triplet repeat at the FMR-1 locus are rapidly and selectively methylated by the human DNA (cytosine-5) methyltransferase. The apparent affinity of the enzyme for the FMR-1 SSC is about tenfold higher than it is for a control Watson-Crick paired duplex. The de novo methylation rate for the SSC is over 150-fold higher than the de novo rate for the control duplex. Methylation of what is generally called a hemi-methylated duplex occurs with a rate enhancement of over 100-fold, while methylation of what can be viewed as a hemi-methylated FMR-1 SSC is actually slower than the de novo rate. The pronounced inhibition of the methyltransferase by the methylated SSC suggests that the enzyme has a higher affinity for the methylated product of its reaction with the SSC than it has for the unmethylated SSC substrate. Gel retardation studies show that the methyltransferase binds selectively to SSCs from the C-rich strand of the FMR-1 triplet repeat. This suggests a two-step stalling process in which the human methyltransferase first selectively methlyates and subsequently stalls at the C-rich strand SSC. Stalling may reflect the inability of the enzyme to release a DNA product that is fixed in a conformation resembling its transition state by the unusual structure of the substrate. In particular, the data suggest that DNA methyltransferase may physically participate in biological processes that lead to dynamic mutation at FMR-1. In general, the data raise the possibility that a two-step stalling process occurs at secondary structures associated with chromosome instability, chromosome remodelling, viral replication or viral integration and may account for the local hypermethylation and global hypomethylation associated with viral and non-viral tumorigenesis.
来自FMR - 1基因座三联体重复序列富含C链的单链构象体(SSC)被人DNA(胞嘧啶 - 5)甲基转移酶快速且选择性地甲基化。该酶对FMR - 1 SSC的表观亲和力比对对照的沃森 - 克里克配对双链体高约10倍。SSC的从头甲基化率比对照双链体的从头甲基化率高150倍以上。通常所说的半甲基化双链体的甲基化速率提高了100倍以上,而可视为半甲基化FMR - 1 SSC的甲基化实际上比从头甲基化速率慢。甲基化的SSC对甲基转移酶有明显的抑制作用,这表明该酶对其与SSC反应的甲基化产物的亲和力比对未甲基化的SSC底物的亲和力更高。凝胶阻滞研究表明甲基转移酶选择性地结合来自FMR - 1三联体重复序列富含C链的SSC。这表明存在一个两步停滞过程,其中人甲基转移酶首先选择性地甲基化,随后在富含C链的SSC处停滞。停滞可能反映了该酶无法释放因底物异常结构而固定在类似其过渡态构象的DNA产物。特别是,数据表明DNA甲基转移酶可能在导致FMR - 1动态突变的生物学过程中实际发挥作用。一般来说,这些数据增加了这样一种可能性,即在与染色体不稳定、染色体重塑、病毒复制或病毒整合相关的二级结构处发生两步停滞过程,并且可能解释了与病毒和非病毒肿瘤发生相关的局部高甲基化和整体低甲基化。